HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Coccia, E. M. Articles by Hovanessian, A. G. Search for Related Content PubMed PubMed Citation Articles by Coccia, E. M. Articles by Hovanessian, A. G. Social Bookmarking                      What's this?

J. Biol. Chem., Vol. 269, Issue 37, 23087-23094, Sep, 1994

Specific inhibition of viral protein synthesis in HIV-infected cells in response to interferon treatment

EM Coccia, B Krust and AG Hovanessian
Unite de Virologie et Immunologie Cellulaire (UA CNRS 1157), Institut Pasteur, Paris, France.

The mechanism of action of different types of interferons (IFN-alpha, - beta, and -gamma) against human immunodeficiency virus (HIV)-1 infection was investigated in chronically infected monocytoid U937 cells and during an acute infection of the T lymphoblastoid CEM cells. Two chronically infected U937 cell populations, obtained independently (referred to as type A and B cells), were analyzed for their response to IFNs. In type A cells, IFNs mainly inhibited virus particle release, whereas in type B cells, the anti-HIV effect of IFNs cells was found to be largely due to a specific inhibition of viral protein synthesis without any apparent effect on total cellular protein synthesis. Interestingly, such a differential inhibition of HIV protein synthesis could also be demonstrated in acutely infected CEM cells in response to treatment with IFN-alpha. Both in chronically infected U937 type B and acutely infected CEM cells, equivalent amounts of nuclear and cytoplasmic HIV-1 mRNA were detected in control and IFN-treated cells in spite of at least 80% inhibition of HIV protein synthesis. Analysis of the distribution of cellular and viral mRNAs on polysomes in HIV-1- infected cells demonstrated that IFN treatment induces a specific block on viral mRNA translation. These results indicate that the antiviral mechanism of IFN on later stages of HIV replication cycle may be partly due to the inhibition of HIV mRNA translation, besides an effect on virus budding or release.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				K. Chen, J. Huang, C. Zhang, S. Huang, G. Nunnari, F.-x. Wang, X. Tong, L. Gao, K. Nikisher, and H. Zhang Alpha Interferon Potently Enhances the Anti-Human Immunodeficiency Virus Type 1 Activity of APOBEC3G in Resting Primary CD4 T Cells. J. Virol., August 1, 2006; 80(15): 7645 - 7657. [Abstract] [Full Text] [PDF]

				C. L. Ong, J. C. Thorpe, P. R. Gorry, S. Bannwarth, A. Jaworowski, J. L. Howard, S. Chung, S. Campbell, H. S. Christensen, G. Clerzius, et al. Low TRBP Levels Support an Innate Human Immunodeficiency Virus Type 1 Resistance in Astrocytes by Enhancing the PKR Antiviral Response J. Virol., October 15, 2005; 79(20): 12763 - 12772. [Abstract] [Full Text] [PDF]

				L. Espert, G. Degols, Y.-L. Lin, T. Vincent, M. Benkirane, and N. Mechti Interferon-induced exonuclease ISG20 exhibits an antiviral activity against human immunodeficiency virus type 1 J. Gen. Virol., August 1, 2005; 86(8): 2221 - 2229. [Abstract] [Full Text] [PDF]

				C. Rogez-Kreuz, B. Maneglier, M. Martin, N. Dereuddre-Bosquet, J. Martal, D. Dormont, and P. Clayette Involvement of IL-6 in the anti-human immunodeficiency virus activity of IFN-{tau} in human macrophages Int. Immunol., August 1, 2005; 17(8): 1047 - 1057. [Abstract] [Full Text] [PDF]

				C. Rogez, M. Martin, N. Dereuddre-Bosquet, J. Martal, D. Dormont, and P. Clayette Anti-Human Immunodeficiency Virus Activity of Tau Interferon in Human Macrophages: Involvement of Cellular Factors and {beta}-Chemokines J. Virol., December 1, 2003; 77(23): 12914 - 12920. [Abstract] [Full Text] [PDF]

				K. E. Gottschalk, P. D. Adams, A. T. Brunger, and H. Kessler Transmembrane signal transduction of the {alpha}IIb{beta}3 integrin Protein Sci., July 1, 2002; 11(7): 1800 - 1812. [Abstract] [Full Text] [PDF]

				D. L. Brassard, M. J. Grace, and R. W. Bordens Interferon-{alpha} as an immunotherapeutic protein J. Leukoc. Biol., April 1, 2002; 71(4): 565 - 581. [Abstract] [Full Text] [PDF]

				M. Iwashiro, K. Peterson, R. J. Messer, I. M. Stromnes, and K. J. Hasenkrug CD4+ T Cells and Gamma Interferon in the Long-Term Control of Persistent Friend Retrovirus Infection J. Virol., January 1, 2001; 75(1): 52 - 60. [Abstract] [Full Text]

				F. Matheux, E. Lauret, V. Rousseau, J. Larghero, B. Boson, B. Vaslin, A. Cheret, E. De Maeyer, D. Dormont, and R. LeGrand Simian immunodeficiency virus resistance of macaques infused with interferon {beta}-engineered lymphocytes J. Gen. Virol., November 1, 2000; 81(11): 2741 - 2750. [Abstract] [Full Text]

				V. Vieillard, S. Jouveshomme, N. Leflour, E. Jean-Pierre, P. Debre, E. De Maeyer, and B. Autran Transfer of Human CD4+ T Lymphocytes Producing Beta Interferon in Hu-PBL-SCID Mice Controls Human Immunodeficiency Virus Infection J. Virol., December 1, 1999; 73(12): 10281 - 10288. [Abstract] [Full Text]

				R. K. Maitra and R. H. Silverman Regulation of Human Immunodeficiency Virus Replication by 2',5'-Oligoadenylate-Dependent RNase L J. Virol., February 1, 1998; 72(2): 1146 - 1152. [Abstract] [Full Text] [PDF]